Hudig D, Allison N J, Pickett T M, Winkler U, Kam C M, Powers J C
Cell and Molecular Biology Graduate Program, University of Nevada, Reno 89557.
J Immunol. 1991 Aug 15;147(4):1360-8.
To kill other cells, lymphocytes can exocytose granules that contain serine proteases and pore-forming proteins (perforins). We report that mechanism-based isocoumarin inhibitors inhibited the proteases and inactivated lysis. When inhibited proteases were restored, lysis was also restored, indicating that the proteases were essential for lysis. We found three new lymphocyte protease activities, "Asp-ase,""Met-ase," and "Ser-ase," which in addition to ly-tryptase and ly-chymase, comprise five different protease activities in rat RNK-16 granules. The general serine protease inhibitor 3,4-dichloroisocoumarin (DCI) inhibited all five protease activities. Essentially all protease molecules were inactivated by DCI before lysis was reduced, as determined from DCI's second order inhibition rate constants for the proteases, the DCI concentrations, and the times of pretreatment needed to block lysis. The pH favoring DCI inhibition of lysis was the pH optimum for protease activity. Isocoumarin reagents acylate, and may sometimes secondarily alkylate, serine protease active sites. Granule proteases, inhibited by DCI acylation, were deacylated with hydroxylamine, restoring both the protease and lytic activities. Hydroxylamine does not restore alkylated proteases and did not restore the lytic activities after inhibition with 4-chloro-7-guanidino-3-(2-phenylethoxy)-isocoumarin, a more alkylating mechanism-based inhibitor designed to react with tryptases. It is improbable that isocoumarin reagents directly inactivated pore-forming proteins because 1) these reagents require protease activation, 2) their nonspecific effects are alkylating, and 3) alkylated proteins are not restored by hydroxylamine. We conclude that serine proteases participate in lysis when lysis is mediated by the complete assembly of granule proteins.
为了杀死其他细胞,淋巴细胞可以通过胞吐作用释放含有丝氨酸蛋白酶和穿孔素(一种成孔蛋白)的颗粒。我们报告称,基于机制的异香豆素抑制剂可抑制这些蛋白酶并使细胞裂解失活。当被抑制的蛋白酶恢复活性时,细胞裂解也得以恢复,这表明蛋白酶对于细胞裂解至关重要。我们发现了三种新的淋巴细胞蛋白酶活性,即“Asp-酶”“Met-酶”和“Ser-酶”,它们与赖氨酰胰蛋白酶和糜酶一起,构成了大鼠RNK-16颗粒中的五种不同蛋白酶活性。通用的丝氨酸蛋白酶抑制剂3,4-二氯异香豆素(DCI)可抑制所有这五种蛋白酶活性。从DCI对蛋白酶的二级抑制速率常数、DCI浓度以及阻断细胞裂解所需的预处理时间可以确定,在细胞裂解减少之前,基本上所有蛋白酶分子都已被DCI灭活。有利于DCI抑制细胞裂解的pH值是蛋白酶活性的最适pH值。异香豆素试剂可酰化丝氨酸蛋白酶活性位点,有时还可能进一步烷基化。被DCI酰化抑制的颗粒蛋白酶可用羟胺脱酰化,从而恢复蛋白酶活性和细胞裂解活性。羟胺不能恢复被烷基化的蛋白酶活性,在用4-氯-7-胍基-3-(2-苯乙氧基)-异香豆素(一种设计用于与胰蛋白酶反应的更具烷基化作用的基于机制的抑制剂)抑制后,也不能恢复细胞裂解活性。异香豆素试剂不太可能直接使成孔蛋白失活,原因如下:1)这些试剂需要蛋白酶激活;2)它们的非特异性作用是烷基化;3)烷基化的蛋白质不能被羟胺恢复活性。我们得出结论,当细胞裂解由颗粒蛋白的完整组装介导时,丝氨酸蛋白酶参与其中。